YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways
- PMID: 32905781
- DOI: 10.1016/j.celrep.2020.108120
YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways
Abstract
N6-methyladenosine (m6A), the most abundant reversible modification on eukaryote messenger RNA, is recognized by a series of readers, including the YT521-B homology domain family (YTHDF) proteins, which are coupled to perform physiological functions. Here, we report that YTHDF2 and YTHDF3, but not YTHDF1, are required for reprogramming of somatic cells into induced pluripotent stem cells (iPSCs). Mechanistically, we found that YTHDF3 recruits the PAN2-PAN3 deadenylase complex and conduces to reprogramming by promoting mRNA clearance of somatic genes, including Tead2 and Tgfb1, which parallels the activity of the YTHDF2-CCR4-NOT deadenylase complex. Ythdf2/3 deficiency represses mesenchymal-to-epithelial transition (MET) and chromatin silencing at loci containing the TEAD motif, contributing to decreased reprogramming efficiency. Moreover, RNA interference of Tgfb1 or the Hippo signaling effectors Yap1, Taz, and Tead2 rescues Ythdf2/3-defective reprogramming. Overall, YTHDF2/3 couples RNA deadenylation and regulation with the clearance of somatic genes and provides insights into iPSC reprogramming at the posttranscriptional level.
Keywords: Hippo signaling pathway; RNA degradation; YTHDFs; reprogramming.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Interests The authors declare no competing interests.
Similar articles
-
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms.Front Immunol. 2023 Mar 14;14:1162607. doi: 10.3389/fimmu.2023.1162607. eCollection 2023. Front Immunol. 2023. PMID: 36999016 Free PMC article. Review.
-
YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex.Nat Commun. 2016 Aug 25;7:12626. doi: 10.1038/ncomms12626. Nat Commun. 2016. PMID: 27558897 Free PMC article.
-
Targeting m6A binding protein YTHDFs for cancer therapy.Bioorg Med Chem. 2023 Jul 15;90:117373. doi: 10.1016/j.bmc.2023.117373. Epub 2023 Jun 12. Bioorg Med Chem. 2023. PMID: 37329678 Review.
-
Molecular Mechanisms Driving mRNA Degradation by m6A Modification.Trends Genet. 2020 Mar;36(3):177-188. doi: 10.1016/j.tig.2019.12.007. Epub 2020 Jan 18. Trends Genet. 2020. PMID: 31964509 Review.
-
YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA.Cell Res. 2017 Mar;27(3):315-328. doi: 10.1038/cr.2017.15. Epub 2017 Jan 20. Cell Res. 2017. PMID: 28106072 Free PMC article.
Cited by
-
METTL3 facilitates immunosurveillance by inhibiting YTHDF2-mediated NLRC5 mRNA degradation in endometrial cancer.Biomark Res. 2023 Apr 21;11(1):43. doi: 10.1186/s40364-023-00479-4. Biomark Res. 2023. PMID: 37085864 Free PMC article.
-
Targeted Demethylation of the TGFβ1 mRNA Promotes Myoblast Proliferation via Activating the SMAD2 Signaling Pathway.Cells. 2023 Mar 24;12(7):1005. doi: 10.3390/cells12071005. Cells. 2023. PMID: 37048078 Free PMC article.
-
N6-methyladenosine reader YTHDF family in biological processes: Structures, roles, and mechanisms.Front Immunol. 2023 Mar 14;14:1162607. doi: 10.3389/fimmu.2023.1162607. eCollection 2023. Front Immunol. 2023. PMID: 36999016 Free PMC article. Review.
-
Ribosome dynamics and mRNA turnover, a complex relationship under constant cellular scrutiny.Wiley Interdiscip Rev RNA. 2021 Nov;12(6):e1658. doi: 10.1002/wrna.1658. Epub 2021 May 5. Wiley Interdiscip Rev RNA. 2021. PMID: 33949788 Free PMC article. Review.
-
The Roles of RNA N6-Methyladenosine in Regulating Stem Cell Fate.Front Cell Dev Biol. 2021 Nov 5;9:765635. doi: 10.3389/fcell.2021.765635. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34805173 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous